Administration of silica or monoclonal antibody to Thy-1 prevents low-dose streptozotocin-induced diabetes in mice
- 1 June 1986
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 12 (5-6) , 289-294
- https://doi.org/10.1016/0165-2478(86)90032-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells.The Journal of Experimental Medicine, 1985
- Administration of silica prevents diabetes in BB-ratsDiabetes, 1985
- Diabetes induction by subdiabetogenic doses of streptozotocin in BALB/cBOM mice. Noninvolvement of host B-lymphocyte functionsDiabetes, 1984
- Irradiation protects against pancreatic islet degeneration and hyperglycaemia following streptozotocin treatment of miceDiabetologia, 1983
- Diabetes susceptibility of BALB/cBOM mice treated with streptozotocin. Inhibition by lethal irradiation and restoration by splenic lymphocytesDiabetes, 1982
- IMMUNOTHERAPY OF TYPE I DIABETESThe Lancet, 1982
- A new model for investigations of T-cell functions in mice: differential immunosuppressive effects of two monoclonal anti-thy-1.2 antibodiesImmunobiology, 1982
- Complete protection from low-dose streptozotocin-induced diabetes in miceNature, 1978
- Streptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes MellitusScience, 1976
- AN EXAMINATION OF THE CYTOTOXIC EFFECTS OF SILICA ON MACROPHAGESThe Journal of Experimental Medicine, 1966